fotemustine has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baruchel, S; Bouffet, E; Gammon, J; Grant, RM; Hargrave, DR; Tariq, N | 1 |
| Crowther, D; Kerbrat, P; Lentz, MA; Mouridsen, HT; Santoro, A; Somers, R; Steward, WP; Tursz, T; van Glabbeke, M; Verweij, J | 1 |
| Berille, J; Bizzari, JP; Jacquillat, C; Khayat, D; Spielmann, M; Tursz, T | 1 |
3 trial(s) available for fotemustine and Sarcoma
| Article | Year |
|---|---|
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
Topics: Adolescent; Anemia; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Infant; Injections, Intravenous; Male; Medulloblastoma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Thrombocytopenia; Treatment Outcome | 2002 |
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia | 1992 |
[Fotemustine: a pilot phase II trial in sarcoma of the soft tissues].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Sarcoma; Soft Tissue Neoplasms | 1991 |